Get the tools used by (smart)2 investors.
SP500 -0.2%DOW -0.1%FTSE 100 -0.7%NIKKEI -0.1%OIL 0.1%GOLD -0.8%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Consensus EBIT, Actual for Insulet Corporation

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PODD: Insulet Corporation

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...

268.32 USD
Price
– USD
Fair Value
–
Upside
160.19 - 289.46
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Insulet Corporation's Consensus EBIT, Actual:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240 K100 M200 M300 M
Performance Summary
  • Insulet's consensus ebit, actual is 308.9 million
  • Looking back at the last 5 years, Insulet's consensus ebit, actual peaked in December 2024 at 308.9 million.
  • Insulet's consensus ebit, actual hit its 5-year low in December 2022 of 37.6 million.

How does Insulet's Consensus EBIT, Actual benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Insulet Corporation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Insulet Consensus EBIT, Actual Benchmarks
NameTickerConsensus EBIT, Actual
Tandem Diabetes Care IncNASDAQGM:TNDM-128.1 M
Sight Sciences IncNASDAQGS:SGHT-50.532 M
Paragon 28 IncNYSE:FNA-40.778 M
Orthopediatrics CorpNASDAQGM:KIDS-35.01 M
HealthcareSECTOR:HLTH.US-26.658 M
Milestone ScientificNYSEAM:MLSS-7.106 M
Neuroone Medical Technologies CorpNASDAQCM:NMTC-
Retractable Technologies IncNYSEAM:RVP-
Precision Optics Corporation IncNASDAQCM:POCI-
Embecta CorpNASDAQGS:EMBC166.8 M
Insulet CorporationNASDAQGS:PODD308.9 M
Edwards Lifesciences CorpNYSE:EW1.514 B

Metric Usage: Consensus EBIT, Actual

Hide this widget
ebit_actual
Slug
number
Datatype
text
Format
current
Default Period
FY, Q
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Consensus EBIT, Actual in the forecast category include:

  • Positive EPS Revisions Ratio, Last 90 Days - Represents a ratio of analysts that have revised EPS forecasts upwards divided by a count of all analysts covering the company in the last 90 days (can be 0).
  • Revenue Forecast Mean Consensus - The mean or average Revenue Forecast submitted by any analyst for the company.
  • Consensus Revenue, Actual - Reported revenue including any adjustments for unusual items proposed by management. This metric is useful for analyst forecast vs actual analysis since deciding which add backs are truly "unusual" is subjective. Consider using "total_rev" slug instead for other analysis.
  • EBITDA Forecast Median Consensus - The median EBITDA Forecast submitted by any analyst for the company.
View Full List

Search for metric or datapoint

Consensus EBIT, Actual

Reported EBIT including any adjustments for unusual items proposed by management. This metric is useful for analyst forecast vs actual analysis since ...

Definition of Consensus EBIT, Actual

Hide this widget
Reported EBIT including any adjustments for unusual items proposed by management. This metric is useful for analyst forecast vs actual analysis since deciding which add backs are truly "unusual" is subjective. Consider using "ebit" slug instead for other analysis.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-359.6 M1.14 B2.64 B4.435 B0200400600800

The chart above depicts the distribution of consensus ebit, actual for companies operating in the Healthcare sector in the Developed economic region. Over 1,595 companies were considered in this analysis, and 1,536 had meaningful values. The average consensus ebit, actual of companies in the sector is 94.627 M with a standard deviation of 513.1 M.

Insulet Corporation's Consensus EBIT, Actual of 308.9 M ranks in the 90.8% percentile for the sector. The following table provides additional summary stats:

Consensus EBIT, Actual In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents1,600
Included Constituents1,536
Min-358.8 M
Max4.329 B
Median-10.114 M
Mean94.627 M
Standard Deviation513.1 M

You can find companies with similar consensus ebit, actual using this stock screener.

All rights reserved. Terms Of Use